Details of the Drug Formulations

General Information of Drug (ID: DM8WI3R)

• Drug Name: Alogliptin Drug Info
• Synonyms: 850649-61-5; UNII-JHC049LO86; alogliptina; 2-({6-[(3r)-3-Aminopiperidin-1-Yl]-3-Methyl-2,4-Dioxo-3,4-Dihydropyrimidin-1(2h)-Yl}methyl)benzonitrile; SYR-322; JHC049LO86; (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile; CHEBI:72323; AK322010; 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl}methyl)benzonitrile; vipidia; Alogliptin [INN]; Alogliptin (SYR-322); alogliptinum; alogliptine; HSDB 8203; UNII-JHC049LO86

Indication

Disease Entry	ICD 11	Status	REF
Type-2 diabetes	5A11	Approved	[1]

• Cross-matching ID:
  PubChem CID: 11450633
  ChEBI ID: CHEBI:72323
  CAS Number: 850649-61-5
  TTD ID: D0NJ5H
  INTEDE ID: DR0071
  ACDINA ID: D00022

Full List of Drug Formulations Containing This Drug

Alogliptin 12.5 mg tablet

Company	Formulation ID	FDA Description
Takeda Pharmaceuticals America	F00742	Butyl alcohol; Magnesium stearate; Mannitol; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Alcohol; Hydroxypropyl cellulose (120000 mw); Hypromellose 2910 (6 mpa.s); Microcrystalline cellulose; Polyethylene glycol 8000; Shellac
Perrigo New York	F00743	Butyl alcohol; Magnesium stearate; Mannitol; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Alcohol; Hydroxypropyl cellulose (120000 mw); Hypromellose 2910 (6 mpa.s); Microcrystalline cellulose; Polyethylene glycol 8000; Shellac

Alogliptin 25 mg tablet

Company	Formulation ID	FDA Description
Takeda Pharmaceuticals America	F00744	Butyl alcohol; Magnesium stearate; Mannitol; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Alcohol; Hydroxypropyl cellulose (120000 mw); Hypromellose 2910 (6 mpa.s); Microcrystalline cellulose; Polyethylene glycol 8000; Shellac
Perrigo New York	F00745	Butyl alcohol; Magnesium stearate; Mannitol; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Alcohol; Hydroxypropyl cellulose (120000 mw); Hypromellose 2910 (6 mpa.s); Microcrystalline cellulose; Polyethylene glycol 8000; Shellac

Alogliptin 6.25 mg tablet

Company	Formulation ID	FDA Description
Takeda Pharmaceuticals America	F00746	Butyl alcohol; Magnesium stearate; Mannitol; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Alcohol; Hydroxypropyl cellulose (120000 mw); Hypromellose 2910 (6 mpa.s); Microcrystalline cellulose; Polyethylene glycol 8000; Shellac
Perrigo New York	F00747	Butyl alcohol; Magnesium stearate; Mannitol; Ferric oxide red; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Alcohol; Hydroxypropyl cellulose (120000 mw); Hypromellose 2910 (6 mpa.s); Microcrystalline cellulose; Polyethylene glycol 8000; Shellac

Alogliptin Benzoate eq 6.25mg base tablet

Company	Formulation ID	FDA Description
Takeda Pharms Usa	F23937	Mannitol; Microcrystalline Cellulose; Hydroxypropyl Cellulose; Croscarmellose Sodium; Magnesium Stearate; Hypromellose; Titanium Dioxide; Ferric Oxide (Red Or Yellow); Polyethylene Glycol; Gray F1 Printing Ink

Alogliptin Benzoate eq 12.5mg base tablet

Company	Formulation ID	FDA Description
Takeda Pharms Usa	F23938	Mannitol; Microcrystalline Cellulose; Hydroxypropyl Cellulose; Croscarmellose Sodium; Magnesium Stearate; Hypromellose; Titanium Dioxide; Ferric Oxide (Red Or Yellow); Polyethylene Glycol; Gray F1 Printing Ink

Alogliptin Benzoate eq 25mg base tablet

Company	Formulation ID	FDA Description
Takeda Pharms Usa	F23939	Mannitol; Microcrystalline Cellulose; Hydroxypropyl Cellulose; Croscarmellose Sodium; Magnesium Stearate; Hypromellose; Titanium Dioxide; Ferric Oxide (Red Or Yellow); Polyethylene Glycol; Gray F1 Printing Ink

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6319).